Beyond Air, Inc. Form 8-K Summary
Business Context and Reporting Period
Beyond Air, Inc. (XAIR), a Delaware corporation, filed this Current Report on Form 8-K on March 20, 2024, regarding a registered direct offering. The offering closed on March 22, 2024. The company is headquartered in Garden City, NY, and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics and Transaction Details
- Offering Structure: Sale of 9,638,556 shares of Common Stock and 9,638,556 Common Stock Warrants.
- Offering Price: $1.66 per share and accompanying warrant.
- Warrant Terms: Immediately exercisable at $2.25 per share; expires three years from issuance.
- Net Proceeds: Approximately $14.6 million after deducting offering expenses and placement agent fees.
- Placement Fees: 7% of aggregate gross proceeds paid to Co-Placement Agents (Roth Capital Partners, LLC and Laidlaw & Company (UK) Ltd).
- Use of Proceeds: Commercial sales development, research, working capital, and general corporate purposes.
Note: This filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the company's ongoing operations.
Material Changes and Agreements
The primary material change is the entry into a Securities Purchase Agreement and a Placement Agency Agreement. The company has agreed to a 90-day lock-up period (until 90 days after March 22, 2024) restricting the issuance of Common Stock or equivalents. Additionally, the company has agreed not to enter into variable rate transactions for six months following the closing of the offering.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance or specific management commentary on future performance metrics. The primary risk factors disclosed relate to the dilution of existing shareholders due to the issuance of new shares and warrants, and the restrictions on future capital raising activities imposed by the lock-up and variable rate transaction covenants.
Key Facts for Investor Verification
- Verify the exact number of shares outstanding post-offering to assess dilution impact.
- Confirm the total gross proceeds raised versus the net proceeds of $14.6 million.
- Review the specific terms of the 90-day lock-up and 6-month variable rate transaction restrictions.
- Monitor the company's utilization of the $14.6 million net proceeds against stated objectives (sales development and R&D).
- Check the exercise price of $2.25 for the warrants relative to the current market price of the stock.